INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Serenoa repens does not improve urinary symptoms or prostate size in BPH.

A systematic review evaluated 32 randomized controlled trials involving 5,666 men with benign prostatic hyperplasia receiving Serenoa repens for 4 to 72 weeks. In pooled analysis of two trials (n = 582), Serenoa repens did not reduce symptom scores compared to placebo (MD 0.25 points, 95% CI -0.58 to 1.07). Even at double and triple doses, treatment failed to meaningfully improve nocturia, peak urine flow, or prostate volume.

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
5,666 men with symptomatic benign prostatic hyperplasia
What was measured
Urologic symptom scores, nocturia, urinary flow, and prostate size

THE PAPER

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Cochrane Database Syst Rev, 2012.

PubMed 23235581 ↗DOI 10.1002/14651858.CD001423.pub3 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.